Table 7.
Study Time Point | No. of Nodules |
No. of Sites |
||
---|---|---|---|---|
Doxycycline | Placebo | Doxycycline | Placebo | |
Baseline | ||||
No. of patients | 71 | 76 | 71 | 76 |
Total No. of nodules/sites | 178 | 182 | 114 | 116 |
Mean ± SD | 2.51 ± 1.40 | 2.39 ± 1.86 | 1.61 ± 0.78 | 1.53 ± 0.81 |
Min–Max | 1–6 | 1–11 | 1–4 | 1–4 |
Median | 2 | 2 | 1 | 1 |
25th, 75th percentiles | 1, 3 | 1, 3 | 1, 2 | 1, 2 |
P valueb | P = .151 | P = .378 | ||
20 mo | ||||
No. of patients | 67 | 69 | 67 | 69 |
Total No. of nodules/sites | 137 | 150 | 98 | 104 |
Mean ± SD | 2.04 ± 1.32 | 2.17 ± 1.68 | 1.46 ± 0.68 | 1.51 ± 0.87 |
Min–Max | 1–6 | 0–8 | 1–4 | 0–4 |
Median | 2 | 2 | 1 | 1 |
25th, 75th percentiles | 1, 3 | 1, 2 | 1, 2 | 1, 2 |
P valueb | P = .858 | P = .903 | ||
Difference 20 mo – baseline | ||||
No. of patients | 67 | 69 | 67 | 69 |
Mean ± SD | −0.43 ± 1.03 | −0.09 ± 1.00 | −0.12 ± 0.54 | 0.01 ± 0.56 |
Min–Max | −5 to 2 | −4 to 2 | −1 to 1 | −2 to 1 |
Median | 0 | 0 | 0 | 0 |
25th, 75th percentiles | −1, 0 | 0, 0 | 0, 0 | 0, 0 |
P valueb | P = .015 | P = .109 | ||
Operatedc | ||||
No. of patients | 66 | 66 | 66 | 66 |
Total No. of nodules/sites | 182 | 227 | 99 | 108 |
Mean ± SD | 2.76 ± 2.18 | 3.44 ± 2.79 | 1.5 ± 0.75 | 1.64 ± 0.97 |
Min–Max | 1–13 | 1–14 | 1–4 | 1–5 |
Median | 2 | 2.5 | 1 | 1 |
25th, 75th percentiles | 1, 3 | 2, 4 | 1, 2 | 1, 2 |
P valueb | P = .126 | P = .591 | ||
Evaluatedd | ||||
No. of patients | 56 | 63 | 56 | 63 |
Total No. of nodules/sites | 152 | 199 | 79 | 97 |
Mean ± SD | 2.71 ± 2.02 | 3.16 ± 2.39 | 1.41 ± 0.73 | 1.54 ± 0.84 |
Min–Max | 1–11 | 1–12 | 1–4 | 1–4 |
Median | 2 | 2 | 1 | 1 |
25th, 75th percentiles | 1, 3 | 2, 4 | 1, 2 | 1, 2 |
P valueb | P = .277 | P = .412 |
Abbreviation: SD, standard deviation.
a The set used here (Treatment-per protocol) includes all people who took the treatment (doxycycline or placebo) according to protocol.
b Mann–Whitney U test.
c In 4 participants, no nodule was found before or after incision.
d Thirteen participants and, in total, 11.5% (n = 47) of all nodules could not be analyzed for parasitic status; the reasons for this exclusion included extensive calcification of the nodule, or being of nononchocercal origin (eg, foreign body granulomas, lipomas, or lymph nodes). An additional 11 nodules were subtracted for containing newly acquired worms only.